Maraviroc
- Product NDC
- 73141-025
- 11-digit product format
- 731410025
- Labeler code
- 73141
- Product ID
- 73141-025_33a02559-b292-1860-e063-6394a90a8868
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Maraviroc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A2A Integrated Pharmaceuticals
- Application
- ANDA217114
- Marketing category
- ANDA
- Marketing start
- 2024-05-16
- Substance
- MARAVIROC
- Active strength
- 300 mg/1
- Pharmacologic classes
- CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Maraviroc
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MARAVIROC | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MD6P741W8A |
| Rxcui | 728223, 728225 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73141-025-02 | Maraviroc | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73141-025 | MARAVIROC TABLET, FILM COATED [A2A INTEGRATED PHARMACEUTICALS] | 2 | Current NDC, 1 package rows | 20250427_2a16417d-a3b8-483b-9dfe-d5263cc16538.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 73141-025-02 | 73141002502 | 60 TABLET, FILM COATED in 1 BOTTLE (73141-025-02) | 2024-05-16 | No | No | Current |